Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Oncolytic Virus Therapy market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Oncolytic Virus Therapy market. Detailed analysis of key players, along with key growth strategies adopted by Oncolytic Virus Therapy industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
TILT Biotherapeutics
PsiOxus Therapeutics
Lokon Pharma
Targovax
SillaJen Biotherapeutics
Transgene SA
Oncolys BioPharma
Vyriad
Viralytics
Oncolytics Biotech
Amgen
Sorrento Therapeutics
Cold Genesys
Genelux Corporation
By Type:
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others
By End-User:
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Oncolytic Virus Therapy Market
-
1.3 Market Segment by Type
-
1.3.1 USA Oncolytic Virus Therapy Market Size and Growth Rate of Melanoma from 2016 to 2027
-
1.3.2 USA Oncolytic Virus Therapy Market Size and Growth Rate of Prostate Cancer from 2016 to 2027
-
1.3.3 USA Oncolytic Virus Therapy Market Size and Growth Rate of Breast Cancer from 2016 to 2027
-
1.3.4 USA Oncolytic Virus Therapy Market Size and Growth Rate of Ovarian Cancer from 2016 to 2027
-
1.3.5 USA Oncolytic Virus Therapy Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Oncolytic Virus Therapy Market Size and Growth Rate of Melanoma from 2016 to 2027
-
1.4.2 USA Oncolytic Virus Therapy Market Size and Growth Rate of Prostate Cancer from 2016 to 2027
-
1.4.3 USA Oncolytic Virus Therapy Market Size and Growth Rate of Breast Cancer from 2016 to 2027
-
1.4.4 USA Oncolytic Virus Therapy Market Size and Growth Rate of Ovarian Cancer from 2016 to 2027
-
1.4.5 USA Oncolytic Virus Therapy Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Oncolytic Virus Therapy Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Oncolytic Virus Therapy by Major Types
-
3.4.1 Market Size and Growth Rate of Melanoma
-
3.4.2 Market Size and Growth Rate of Prostate Cancer
-
3.4.3 Market Size and Growth Rate of Breast Cancer
-
3.4.4 Market Size and Growth Rate of Ovarian Cancer
-
3.4.5 Market Size and Growth Rate of Others
4 Segmentation of Oncolytic Virus Therapy Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Oncolytic Virus Therapy by Major End-Users
-
4.4.1 Market Size and Growth Rate of Oncolytic Virus Therapy in Melanoma
-
4.4.2 Market Size and Growth Rate of Oncolytic Virus Therapy in Prostate Cancer
-
4.4.3 Market Size and Growth Rate of Oncolytic Virus Therapy in Breast Cancer
-
4.4.4 Market Size and Growth Rate of Oncolytic Virus Therapy in Ovarian Cancer
-
4.4.5 Market Size and Growth Rate of Oncolytic Virus Therapy in Others
5 Market Analysis by Regions
-
5.1 USA Oncolytic Virus Therapy Production Analysis by Regions
-
5.2 USA Oncolytic Virus Therapy Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Oncolytic Virus Therapy Landscape Analysis
-
6.1 West USA Oncolytic Virus Therapy Landscape Analysis by Major Types
-
6.2 West USA Oncolytic Virus Therapy Landscape Analysis by Major End-Users
7 South USA Oncolytic Virus Therapy Landscape Analysis
-
7.1 South USA Oncolytic Virus Therapy Landscape Analysis by Major Types
-
7.2 South USA Oncolytic Virus Therapy Landscape Analysis by Major End-Users
8 Middle West USA Oncolytic Virus Therapy Landscape Analysis
-
8.1 Middle West USA Oncolytic Virus Therapy Landscape Analysis by Major Types
-
8.2 Middle West USA Oncolytic Virus Therapy Landscape Analysis by Major End-Users
9 Northeast USA Oncolytic Virus Therapy Landscape Analysis
-
9.1 Northeast USA Oncolytic Virus Therapy Landscape Analysis by Major Types
-
9.2 Northeast USA Oncolytic Virus Therapy Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 TILT Biotherapeutics
-
10.1.1 TILT Biotherapeutics Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 PsiOxus Therapeutics
-
10.2.1 PsiOxus Therapeutics Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Lokon Pharma
-
10.3.1 Lokon Pharma Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Targovax
-
10.4.1 Targovax Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 SillaJen Biotherapeutics
-
10.5.1 SillaJen Biotherapeutics Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Transgene SA
-
10.6.1 Transgene SA Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Oncolys BioPharma
-
10.7.1 Oncolys BioPharma Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Vyriad
-
10.8.1 Vyriad Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Viralytics
-
10.9.1 Viralytics Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Oncolytics Biotech
-
10.10.1 Oncolytics Biotech Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 Amgen
-
10.11.1 Amgen Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
-
10.12 Sorrento Therapeutics
-
10.12.1 Sorrento Therapeutics Company Profile and Recent Development
-
10.12.2 Market Performance
-
10.12.3 Product and Service Introduction
-
10.13 Cold Genesys
-
10.13.1 Cold Genesys Company Profile and Recent Development
-
10.13.2 Market Performance
-
10.13.3 Product and Service Introduction
-
10.14 Genelux Corporation
-
10.14.1 Genelux Corporation Company Profile and Recent Development
-
10.14.2 Market Performance
-
10.14.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Oncolytic Virus Therapy Market Size and Growth Rate of Melanoma from 2016 to 2027
-
Figure USA Oncolytic Virus Therapy Market Size and Growth Rate of Prostate Cancer from 2016 to 2027
-
Figure USA Oncolytic Virus Therapy Market Size and Growth Rate of Breast Cancer from 2016 to 2027
-
Figure USA Oncolytic Virus Therapy Market Size and Growth Rate of Ovarian Cancer from 2016 to 2027
-
Figure USA Oncolytic Virus Therapy Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Oncolytic Virus Therapy Market Size and Growth Rate of Melanoma from 2016 to 2027
-
Figure USA Oncolytic Virus Therapy Market Size and Growth Rate of Prostate Cancer from 2016 to 2027
-
Figure USA Oncolytic Virus Therapy Market Size and Growth Rate of Breast Cancer from 2016 to 2027
-
Figure USA Oncolytic Virus Therapy Market Size and Growth Rate of Ovarian Cancer from 2016 to 2027
-
Figure USA Oncolytic Virus Therapy Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Oncolytic Virus Therapy Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Oncolytic Virus Therapy
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Oncolytic Virus Therapy by Different Types from 2016 to 2027
-
Table Consumption Share of Oncolytic Virus Therapy by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Melanoma
-
Figure Market Size and Growth Rate of Prostate Cancer
-
Figure Market Size and Growth Rate of Breast Cancer
-
Figure Market Size and Growth Rate of Ovarian Cancer
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Oncolytic Virus Therapy by Different End-Users from 2016 to 2027
-
Table Consumption Share of Oncolytic Virus Therapy by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Melanoma
-
Figure Market Size and Growth Rate of Prostate Cancer
-
Figure Market Size and Growth Rate of Breast Cancer
-
Figure Market Size and Growth Rate of Ovarian Cancer
-
Figure Market Size and Growth Rate of Others
-
Table USA Oncolytic Virus Therapy Production by Regions
-
Table USA Oncolytic Virus Therapy Production Share by Regions
-
Figure USA Oncolytic Virus Therapy Production Share by Regions in 2016
-
Figure USA Oncolytic Virus Therapy Production Share by Regions in 2021
-
Figure USA Oncolytic Virus Therapy Production Share by Regions in 2027
-
Table USA Oncolytic Virus Therapy Consumption by Regions
-
Table USA Oncolytic Virus Therapy Consumption Share by Regions
-
Figure USA Oncolytic Virus Therapy Consumption Share by Regions in 2016
-
Figure USA Oncolytic Virus Therapy Consumption Share by Regions in 2021
-
Figure USA Oncolytic Virus Therapy Consumption Share by Regions in 2027
-
Table West USA Oncolytic Virus Therapy Consumption by Types from 2016 to 2027
-
Table West USA Oncolytic Virus Therapy Consumption Share by Types from 2016 to 2027
-
Figure West USA Oncolytic Virus Therapy Consumption Share by Types in 2016
-
Figure West USA Oncolytic Virus Therapy Consumption Share by Types in 2021
-
Figure West USA Oncolytic Virus Therapy Consumption Share by Types in 2027
-
Table West USA Oncolytic Virus Therapy Consumption by End-Users from 2016 to 2027
-
Table West USA Oncolytic Virus Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Oncolytic Virus Therapy Consumption Share by End-Users in 2016
-
Figure West USA Oncolytic Virus Therapy Consumption Share by End-Users in 2021
-
Figure West USA Oncolytic Virus Therapy Consumption Share by End-Users in 2027
-
Table South USA Oncolytic Virus Therapy Consumption by Types from 2016 to 2027
-
Table South USA Oncolytic Virus Therapy Consumption Share by Types from 2016 to 2027
-
Figure South USA Oncolytic Virus Therapy Consumption Share by Types in 2016
-
Figure South USA Oncolytic Virus Therapy Consumption Share by Types in 2021
-
Figure South USA Oncolytic Virus Therapy Consumption Share by Types in 2027
-
Table South USA Oncolytic Virus Therapy Consumption by End-Users from 2016 to 2027
-
Table South USA Oncolytic Virus Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Oncolytic Virus Therapy Consumption Share by End-Users in 2016
-
Figure South USA Oncolytic Virus Therapy Consumption Share by End-Users in 2021
-
Figure South USA Oncolytic Virus Therapy Consumption Share by End-Users in 2027
-
Table Middle West USA Oncolytic Virus Therapy Consumption by Types from 2016 to 2027
-
Table Middle West USA Oncolytic Virus Therapy Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Oncolytic Virus Therapy Consumption Share by Types in 2016
-
Figure Middle West USA Oncolytic Virus Therapy Consumption Share by Types in 2021
-
Figure Middle West USA Oncolytic Virus Therapy Consumption Share by Types in 2027
-
Table Middle West USA Oncolytic Virus Therapy Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Oncolytic Virus Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Oncolytic Virus Therapy Consumption Share by End-Users in 2016
-
Figure Middle West USA Oncolytic Virus Therapy Consumption Share by End-Users in 2021
-
Figure Middle West USA Oncolytic Virus Therapy Consumption Share by End-Users in 2027
-
Table Northeast USA Oncolytic Virus Therapy Consumption by Types from 2016 to 2027
-
Table Northeast USA Oncolytic Virus Therapy Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Oncolytic Virus Therapy Consumption Share by Types in 2016
-
Figure Northeast USA Oncolytic Virus Therapy Consumption Share by Types in 2021
-
Figure Northeast USA Oncolytic Virus Therapy Consumption Share by Types in 2027
-
Table Northeast USA Oncolytic Virus Therapy Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Oncolytic Virus Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Oncolytic Virus Therapy Consumption Share by End-Users in 2016
-
Figure Northeast USA Oncolytic Virus Therapy Consumption Share by End-Users in 2021
-
Figure Northeast USA Oncolytic Virus Therapy Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of TILT Biotherapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of TILT Biotherapeutics
-
Figure Sales and Growth Rate Analysis of TILT Biotherapeutics
-
Figure Revenue and Market Share Analysis of TILT Biotherapeutics
-
Table Product and Service Introduction of TILT Biotherapeutics
-
Table Company Profile and Development Status of PsiOxus Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of PsiOxus Therapeutics
-
Figure Sales and Growth Rate Analysis of PsiOxus Therapeutics
-
Figure Revenue and Market Share Analysis of PsiOxus Therapeutics
-
Table Product and Service Introduction of PsiOxus Therapeutics
-
Table Company Profile and Development Status of Lokon Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lokon Pharma
-
Figure Sales and Growth Rate Analysis of Lokon Pharma
-
Figure Revenue and Market Share Analysis of Lokon Pharma
-
Table Product and Service Introduction of Lokon Pharma
-
Table Company Profile and Development Status of Targovax
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Targovax
-
Figure Sales and Growth Rate Analysis of Targovax
-
Figure Revenue and Market Share Analysis of Targovax
-
Table Product and Service Introduction of Targovax
-
Table Company Profile and Development Status of SillaJen Biotherapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of SillaJen Biotherapeutics
-
Figure Sales and Growth Rate Analysis of SillaJen Biotherapeutics
-
Figure Revenue and Market Share Analysis of SillaJen Biotherapeutics
-
Table Product and Service Introduction of SillaJen Biotherapeutics
-
Table Company Profile and Development Status of Transgene SA
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Transgene SA
-
Figure Sales and Growth Rate Analysis of Transgene SA
-
Figure Revenue and Market Share Analysis of Transgene SA
-
Table Product and Service Introduction of Transgene SA
-
Table Company Profile and Development Status of Oncolys BioPharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Oncolys BioPharma
-
Figure Sales and Growth Rate Analysis of Oncolys BioPharma
-
Figure Revenue and Market Share Analysis of Oncolys BioPharma
-
Table Product and Service Introduction of Oncolys BioPharma
-
Table Company Profile and Development Status of Vyriad
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vyriad
-
Figure Sales and Growth Rate Analysis of Vyriad
-
Figure Revenue and Market Share Analysis of Vyriad
-
Table Product and Service Introduction of Vyriad
-
Table Company Profile and Development Status of Viralytics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Viralytics
-
Figure Sales and Growth Rate Analysis of Viralytics
-
Figure Revenue and Market Share Analysis of Viralytics
-
Table Product and Service Introduction of Viralytics
-
Table Company Profile and Development Status of Oncolytics Biotech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Oncolytics Biotech
-
Figure Sales and Growth Rate Analysis of Oncolytics Biotech
-
Figure Revenue and Market Share Analysis of Oncolytics Biotech
-
Table Product and Service Introduction of Oncolytics Biotech
-
Table Company Profile and Development Status of Amgen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen
-
Figure Sales and Growth Rate Analysis of Amgen
-
Figure Revenue and Market Share Analysis of Amgen
-
Table Product and Service Introduction of Amgen
-
Table Company Profile and Development Status of Sorrento Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sorrento Therapeutics
-
Figure Sales and Growth Rate Analysis of Sorrento Therapeutics
-
Figure Revenue and Market Share Analysis of Sorrento Therapeutics
-
Table Product and Service Introduction of Sorrento Therapeutics
-
Table Company Profile and Development Status of Cold Genesys
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cold Genesys
-
Figure Sales and Growth Rate Analysis of Cold Genesys
-
Figure Revenue and Market Share Analysis of Cold Genesys
-
Table Product and Service Introduction of Cold Genesys
-
Table Company Profile and Development Status of Genelux Corporation
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genelux Corporation
-
Figure Sales and Growth Rate Analysis of Genelux Corporation
-
Figure Revenue and Market Share Analysis of Genelux Corporation
-
Table Product and Service Introduction of Genelux Corporation
-
